In particular, these SLNs are further altered by EGFR-targeted L peptide and mitochondrion-directed K peptide to increase targeting of Afa and/or miR towards GC cells and, thus, activate mitochondrion-mediated GC cell death. This evidence concerns the gene EGFR and gastric cancer.